Our findings indicate that the level of CD3+CD8+ CTLs is lower in preoperative patients with breast cancer than in healthy individuals and inversely correlates with tumor stage, positive lymphatic tumor emboli, and nodal stage N3. The gene discussed is CD8A; the disease is breast carcinoma.